Crystal engineering of the composition of pharmaceutical phases

R. D. Bailey Walsh; M. W. Bradner; S. Fleischman; L. A. Morales; B. Moulton; N. Rodríguez-Hornedo; M. J. Zaworotko

doi:10.1039/b208574g

Crystal engineering of the composition of pharmaceutical phases

R. D. Bailey Walsh
, M. W. Bradner
, S. Fleischman
, L. A. Morales
, B. Moulton
, N. Rodríguez-Hornedo
, M. J. Zaworotko

Research output: Contribution to journal › Article › peer-review

Abstract

The carboxylic acid-pyridine supramolecular heterosynthon can be exploited to predictably generate binary crystalline phases involving rac-ibuprofen, rac-flurbiprofen or aspirin.

Original language	English
Pages (from-to)	186-187
Number of pages	2
Journal	Chemical Communications
Issue number	2
DOIs	https://doi.org/10.1039/b208574g
Publication status	Published - 2003
Externally published	Yes

Access to Document

10.1039/b208574g

Cite this

@article{d66e9c511d8d4ce297e4693fffe98d4d,

title = "Crystal engineering of the composition of pharmaceutical phases",

abstract = "The carboxylic acid-pyridine supramolecular heterosynthon can be exploited to predictably generate binary crystalline phases involving rac-ibuprofen, rac-flurbiprofen or aspirin.",

author = "\{Bailey Walsh\}, \{R. D.\} and Bradner, \{M. W.\} and S. Fleischman and Morales, \{L. A.\} and B. Moulton and N. Rodr{\'i}guez-Hornedo and Zaworotko, \{M. J.\}",

year = "2003",

doi = "10.1039/b208574g",

language = "English",

pages = "186--187",

journal = "Chemical Communications",

issn = "1359-7345",

number = "2",

}

TY - JOUR

T1 - Crystal engineering of the composition of pharmaceutical phases

AU - Bailey Walsh, R. D.

AU - Bradner, M. W.

AU - Fleischman, S.

AU - Morales, L. A.

AU - Moulton, B.

AU - Rodríguez-Hornedo, N.

AU - Zaworotko, M. J.

PY - 2003

Y1 - 2003

N2 - The carboxylic acid-pyridine supramolecular heterosynthon can be exploited to predictably generate binary crystalline phases involving rac-ibuprofen, rac-flurbiprofen or aspirin.

AB - The carboxylic acid-pyridine supramolecular heterosynthon can be exploited to predictably generate binary crystalline phases involving rac-ibuprofen, rac-flurbiprofen or aspirin.

UR - https://www.scopus.com/pages/publications/0037250424

U2 - 10.1039/b208574g

DO - 10.1039/b208574g

M3 - Article

C2 - 12585383

AN - SCOPUS:0037250424

SN - 1359-7345

SP - 186

EP - 187

JO - Chemical Communications

JF - Chemical Communications

IS - 2

ER -

Crystal engineering of the composition of pharmaceutical phases

Abstract

Access to Document

Other files and links

Fingerprint

Cite this